301 related articles for article (PubMed ID: 18996881)
1. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers.
Vulevic J; Drakoularakou A; Yaqoob P; Tzortzis G; Gibson GR
Am J Clin Nutr; 2008 Nov; 88(5):1438-46. PubMed ID: 18996881
[TBL] [Abstract][Full Text] [Related]
2. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.
Vulevic J; Juric A; Tzortzis G; Gibson GR
J Nutr; 2013 Mar; 143(3):324-31. PubMed ID: 23303873
[TBL] [Abstract][Full Text] [Related]
3. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.
Vulevic J; Juric A; Walton GE; Claus SP; Tzortzis G; Toward RE; Gibson GR
Br J Nutr; 2015 Aug; 114(4):586-95. PubMed ID: 26218845
[TBL] [Abstract][Full Text] [Related]
4. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.
Bouhnik Y; Achour L; Paineau D; Riottot M; Attar A; Bornet F
Nutr J; 2007 Dec; 6():42. PubMed ID: 18053236
[TBL] [Abstract][Full Text] [Related]
5. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study.
Depeint F; Tzortzis G; Vulevic J; I'anson K; Gibson GR
Am J Clin Nutr; 2008 Mar; 87(3):785-91. PubMed ID: 18326619
[TBL] [Abstract][Full Text] [Related]
6. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.
Childs CE; Röytiö H; Alhoniemi E; Fekete AA; Forssten SD; Hudjec N; Lim YN; Steger CJ; Yaqoob P; Tuohy KM; Rastall RA; Ouwehand AC; Gibson GR
Br J Nutr; 2014 Jun; 111(11):1945-56. PubMed ID: 24661576
[TBL] [Abstract][Full Text] [Related]
7. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
8. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity--a randomized, double-blind, placebo-controlled study.
Shadid R; Haarman M; Knol J; Theis W; Beermann C; Rjosk-Dendorfer D; Schendel DJ; Koletzko BV; Krauss-Etschmann S
Am J Clin Nutr; 2007 Nov; 86(5):1426-37. PubMed ID: 17991656
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial.
Yen CH; Kuo YW; Tseng YH; Lee MC; Chen HL
Nutrition; 2011 Mar; 27(3):323-8. PubMed ID: 20579847
[TBL] [Abstract][Full Text] [Related]
10. In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own.
Piirainen L; Kekkonen RA; Kajander K; Ahlroos T; Tynkkynen S; Nevala R; Korpela R
Ann Nutr Metab; 2008; 52(3):204-8. PubMed ID: 18544974
[TBL] [Abstract][Full Text] [Related]
11. Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress.
Wilms E; An R; Smolinska A; Stevens Y; Weseler AR; Elizalde M; Drittij MJ; Ioannou A; van Schooten FJ; Smidt H; Masclee AAM; Zoetendal EG; Jonkers DMAE
Clin Nutr; 2021 May; 40(5):3019-3031. PubMed ID: 33509667
[TBL] [Abstract][Full Text] [Related]
12. Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
Nyangale EP; Farmer S; Cash HA; Keller D; Chernoff D; Gibson GR
J Nutr; 2015 Jul; 145(7):1446-52. PubMed ID: 25948780
[TBL] [Abstract][Full Text] [Related]
13. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Bartosch S; Woodmansey EJ; Paterson JC; McMurdo ME; Macfarlane GT
Clin Infect Dis; 2005 Jan; 40(1):28-37. PubMed ID: 15614689
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
[TBL] [Abstract][Full Text] [Related]
15. A probiotic mixture including galactooligosaccharides decreases fecal β-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention.
Kekkonen RA; Holma R; Hatakka K; Suomalainen T; Poussa T; Adlercreutz H; Korpela R
J Nutr; 2011 May; 141(5):870-6. PubMed ID: 21411613
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
Silk DB; Davis A; Vulevic J; Tzortzis G; Gibson GR
Aliment Pharmacol Ther; 2009 Mar; 29(5):508-18. PubMed ID: 19053980
[TBL] [Abstract][Full Text] [Related]
17. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
Bouhnik Y; Raskine L; Simoneau G; Vicaut E; Neut C; Flourié B; Brouns F; Bornet FR
Am J Clin Nutr; 2004 Dec; 80(6):1658-64. PubMed ID: 15585783
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
[TBL] [Abstract][Full Text] [Related]
19. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
Gill HS; Rutherfurd KJ; Cross ML; Gopal PK
Am J Clin Nutr; 2001 Dec; 74(6):833-9. PubMed ID: 11722966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
